Teva Wins FDA Approval for Monthly Schizophrenia Injection Weltruza
Weltruza FDA approval gives Teva a once-monthly subcutaneous olanzapine injection for adults with schizophrenia. Doses, trial data, safety, launch.
Tag: SOLARIS trial
Read More